ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 67 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $360,159 | +1643.1% | 282,478 | +624.6% | 0.00% | – |
| Q4 2022 | $20,662 | -55.1% | 38,984 | -38.3% | 0.00% | – |
| Q3 2022 | $46,000 | -64.6% | 63,215 | -0.2% | 0.00% | – |
| Q1 2022 | $130,000 | -54.7% | 63,346 | -36.5% | 0.00% | – |
| Q4 2021 | $287,000 | -60.2% | 99,705 | -41.4% | 0.00% | – |
| Q3 2021 | $721,000 | +41.1% | 170,184 | +76.5% | 0.00% | – |
| Q2 2021 | $511,000 | -36.9% | 96,399 | -44.6% | 0.00% | – |
| Q1 2021 | $810,000 | +73.8% | 174,131 | +26.0% | 0.00% | – |
| Q2 2020 | $466,000 | +441.9% | 138,145 | +1116.9% | 0.00% | – |
| Q3 2019 | $86,000 | -64.8% | 11,352 | -37.0% | 0.00% | – |
| Q2 2019 | $244,000 | +577.8% | 18,005 | +46.8% | 0.00% | – |
| Q4 2018 | $36,000 | -87.6% | 12,267 | -65.5% | 0.00% | -100.0% |
| Q3 2018 | $290,000 | +21.3% | 35,555 | +44.6% | 0.00% | 0.0% |
| Q2 2018 | $239,000 | – | 24,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prentice Capital Management, LP | 390,381 | $1,292,000 | 0.49% |
| ETF MANAGERS GROUP, LLC | 891,025 | $2,949,000 | 0.09% |
| AdvisorShares Investments LLC | 353,009 | $1,168,000 | 0.06% |
| ALGERT GLOBAL LLC | 51,028 | $169,000 | 0.05% |
| Bernardo Wealth Planning LLC | 27,219 | $90,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 31,552 | $104,000 | 0.03% |
| ZEKE CAPITAL ADVISORS, LLC | 49,700 | $165,000 | 0.02% |
| Walleye Capital LLC | 51,554 | $171,000 | 0.02% |
| Dynamic Technology Lab Private Ltd | 19,021 | $63,000 | 0.01% |
| J.W. COLE ADVISORS, INC. | 37,064 | $123,000 | 0.01% |